Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niccolò Bartalucci

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
International Review of Cell and Molecular Biology|February 14, 2022
Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectivesNiccolò Bartalucci, Lorenzo Galluzzi
International Review of Cell and Molecular Biology|November 10, 2021
Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectivesNiccolò Bartalucci, Lorenzo Galluzzi
Methods in Cell Biology|August 11, 2022
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cellsLaura Calabresi, Manjola Balliu, Niccolò Bartalucci
Trends in Genetics : TIG|December 15, 2021
A blood drop through the pore: nanopore sequencing in hematologyNiccolò Bartalucci, Simone Romagnoli, Alessandro Maria Vannucchi
Current Hematologic Malignancy Reports|October 23, 2013
Preclinical models for drug selection in myeloproliferative neoplasmsNiccolò Bartalucci, Costanza Bogani, Alessandro M Vannucchi
Frontiers in Genetics|September 7, 2023
Resolving complex structural variants via nanopore sequencingSimone Romagnoli, Niccolò Bartalucci, Alessandro Maria Vannucchi
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Rationale for targeting the PI3K/Akt/mTOR pathway in myeloproliferative neoplasmsNiccolò Bartalucci, Paola Guglielmelli, Alessandro M Vannucchi
Expert Opinion on Therapeutic Targets|May 6, 2020
Polycythemia vera: the current status of preclinical models and therapeutic targetsNiccolò Bartalucci, Paola Guglielmelli, Alessandro M Vannucchi
Dalton Transactions (Cambridge, England : 2003)|April 11, 2019
Decarbonylation of phenylacetic acids by high valent transition metal halidesNiccolò Bartalucci, Fabio Marchetti, Stefano Zacchini, et al.
Expert Review of Hematology|May 23, 2014
Calreticulin: a new horizon for the testing and treatment of myeloproliferative neoplasmsPaola Guglielmelli, Niccolò Bartalucci, Giada Rotunno, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
International Review of Cell and Molecular Biology|February 14, 2022
Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectivesNiccolò Bartalucci, Lorenzo Galluzzi
International Review of Cell and Molecular Biology|November 10, 2021
Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectivesNiccolò Bartalucci, Lorenzo Galluzzi
Methods in Cell Biology|August 11, 2022
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cellsLaura Calabresi, Manjola Balliu, Niccolò Bartalucci
Trends in Genetics : TIG|December 15, 2021
A blood drop through the pore: nanopore sequencing in hematologyNiccolò Bartalucci, Simone Romagnoli, Alessandro Maria Vannucchi
Current Hematologic Malignancy Reports|October 23, 2013
Preclinical models for drug selection in myeloproliferative neoplasmsNiccolò Bartalucci, Costanza Bogani, Alessandro M Vannucchi
Frontiers in Genetics|September 7, 2023
Resolving complex structural variants via nanopore sequencingSimone Romagnoli, Niccolò Bartalucci, Alessandro Maria Vannucchi
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Rationale for targeting the PI3K/Akt/mTOR pathway in myeloproliferative neoplasmsNiccolò Bartalucci, Paola Guglielmelli, Alessandro M Vannucchi
Expert Opinion on Therapeutic Targets|May 6, 2020
Polycythemia vera: the current status of preclinical models and therapeutic targetsNiccolò Bartalucci, Paola Guglielmelli, Alessandro M Vannucchi
Dalton Transactions (Cambridge, England : 2003)|April 11, 2019
Decarbonylation of phenylacetic acids by high valent transition metal halidesNiccolò Bartalucci, Fabio Marchetti, Stefano Zacchini, et al.
Expert Review of Hematology|May 23, 2014
Calreticulin: a new horizon for the testing and treatment of myeloproliferative neoplasmsPaola Guglielmelli, Niccolò Bartalucci, Giada Rotunno, et al.
Pageof 5